RM
Therapeutic Areas
Arcadia Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GoodWheat™ | Reduced-carb, high-fiber, high-protein food ingredient | Commercial |
| HB4® Wheat (Water Use Efficiency) | Drought-tolerant wheat for sustainable farming | Regulatory & Pre-Commercial |
| High Fiber Wheat | Wheat with increased dietary fiber | Advanced Development |
| High Oleic Soybean | Soybean with improved oil stability and health profile | Commercial |
| Arcadia Specialty Hemp (Grain/Fiber) | Hemp for grain and fiber production | Commercial |
| Proprietary Hemp Genetics (CBD) | Hemp for cannabinoid (e.g., CBD) production | R&D / Early Commercial |
Leadership Team at Arcadia Biosciences
MT
Matthew T. Plavan
Chief Executive Officer
SJ
Stanley J. Jacot
Chief Financial Officer
SR
Sarah Reiter
Chief Business Officer
RK
Raj Ketkar
President & Chief Operating Officer
PH
Pamela Haley
Interim Chief Accounting Officer
JG
James G. Levine
Vice President, General Counsel & Corporate Secretary
KL
Kevin L. Comcowich
Chairman of the Board
IP
Ivan P. Delevic
Director
WA
William A. Schmitz
Director